1.
Cornetta K, Laughlin M, Carter S, Wall D, Weinthal J, Delaney C, Wagner J, Sweetman R, McCarthy P, Chao N: Umbilical cord blood transplantation in adults: results of the prospective Cord Blood Transplantation (COBLT).Biol Blood Marrow Transplant 2005, 11:149-160.
2.
Schonberger S, Niehues T, Meisel R, Bernbeck B, Laws HJ, Kogler G, Enzmann J, Wernet P, Gobel U, Dilloo D: Transplantation of haematopoietic stem cells derived from cord blood, bone marrow or peripheral blood: a single centre matched-pair analysis in a heterogeneous risk population.Klin Padiatr 2004, 216:356-363.
3.
Lekakis L, Giralt S, Couriel D, Shpall EJ, Hosing C, Khouri IF, Anderlini P, Korbling M, Martin T, Champlin RE, de Lima M: Phase II study of unrelated cord blood transplantation for adults with high-risk hematologic malignancies.Bone Marrow Transplant 2006, 38:421-426.
4.
Tomonari A, Takahashi S, Ooi J, Nakaoka T, Takasugi K, Uchiyama M, Tsukada N, Konuma T, Iseki T, Tojo A, Asano S: Cord blood transplantation for acute myelogenous leukemia using a conditioning regimen consisting of granulocyte colony-stimulating factor-combined high-dose cytarabine, fludarabine, and total body irradiation.Eur J Haematol 2006, 77:46-50.
5.
Laporte JP, Lesage S, Portnoi MF, Landman J, Rubinstein P, Najman A, Gorin NC: Unrelated mismatched cord blood transplantation in patients with hematological malignancies: a single institution experience.Bone Marrow Transplant 1998, 22 Suppl 1:S76-7.
6.
Sanz GF, Saavedra S, Jimenez C, Senent L, Cervera J, Planelles D, Bolufer P, Larrea L, Martin G, Martinez J, Jarque I, Moscardo F, Plume G, Andreu R, de la Rubia J, Barragan E, Solves P, Soler MA, Sanz MA: Unrelated donor cord blood transplantation in adults with chronic myelogenous leukemia: results in nine patients from a single institution.Bone Marrow Transplant 2001, 27:693-701.
7.
Knutsen AP, Wall DA: Umbilical cord blood transplantation in severe T-cell immunodeficiency disorders: two-year experience.J Clin Immunol 2000, 20:466-476.
8.
Jaing TH, Hung IJ, Yang CP, Chen SH, Sun CF, Chow R: Rapid and complete donor chimerism after unrelated mismatched cord blood transplantation in 5 children with beta-thalassemia major.Biol Blood Marrow Transplant 2005, 11:349-353.
9.
Tomonari A, Tojo A, Takahashi T, Iseki T, Ooi J, Takahashi S, Nagamura F, Uchimaru K, Asano S: Resolution of Behcet's disease after HLA-mismatched unrelated cord blood transplantation for myelodysplastic syndrome.Ann Hematol 2004, 83:464-466.
10.
Brzoska E, Grabowska I, Hoser G, Streminska W, Wasilewska D, Machaj EK, Pojda Z, Moraczewski J, Kawiak J: Participation of stem cells from human cord blood in skeletal muscle regeneration of SCID mice.Exp Hematol 2006, 34:1262-1270.
11.
Hu CH, Wu GF, Wang XQ, Yang YH, Du ZM, He XH, Xiang P: Transplanted human umbilical cord blood mononuclear cells improve left ventricular function through angiogenesis in myocardial infarction.Chin Med J (Engl) 2006, 119:1499-1506.
12.
Leor J, Guetta E, Feinberg MS, Galski H, Bar I, Holbova R, Miller L, Zarin P, Castel D, Barbash IM, Nagler A: Human umbilical cord blood-derived CD133+ cells enhance function and repair of the infarcted myocardium.Stem Cells 2006, 24:772-780.
13.
Newcomb JD, Ajmo CT Jr., Sanberg CD, Sanberg PR, Pennypacker KR, Willing AE: Timing of cord blood treatment after experimental stroke determines therapeutic efficacy.Cell Transplant 2006, 15:213-223.
14.
Escolar ML, Poe MD, Provenzale JM, Richards KC, Allison J, Wood S, Wenger DA, Pietryga D, Wall D, Champagne M, Morse R, Krivit W, Kurtzberg J: Transplantation of umbilical-cord blood in babies with infantile Krabbe's disease.N Engl J Med 2005, 352:2069-2081.
15.
Theunissen K, Verfaillie CM: A multifactorial analysis of umbilical cord blood, adult bone marrow and mobilized peripheral blood progenitors using the improved ML-IC assay.Exp Hematol 2005, 33:165-172.
16.
Ng YY, van Kessel B, Lokhorst HM, Baert MR, van den Burg CM, Bloem AC, Staal FJ: Gene-expression profiling of CD34+ cells from various hematopoietic stem-cell sources reveals functional differences in stem-cell activity.J Leukoc Biol 2004, 75:314-323.
17.
Hogan CJ, Shpall EJ, McNulty O, McNiece I, Dick JE, Shultz LD, Keller G: Engraftment and development of human CD34(+)-enriched cells from umbilical cord blood in NOD/LtSz-scid/scid mice.Blood 1997, 90:85-96.
18.
Sakabe H, Yahata N, Kimura T, Zeng ZZ, Minamiguchi H, Kaneko H, Mori KJ, Ohyashiki K, Ohyashiki JH, Toyama K, Abe T, Sonoda Y: Human cord blood-derived primitive progenitors are enriched in CD34+c-kit- cells: correlation between long-term culture-initiating cells and telomerase expression.Leukemia 1998, 12:728-734.
19.
Hildbrand P, Cirulli V, Prinsen RC, Smith KA, Torbett BE, Salomon DR, Crisa L: The role of angiopoietins in the development of endothelial cells from cord blood CD34+ progenitors.Blood 2004, 104:2010-2019.
20.
Salven P, Mustjoki S, Alitalo R, Alitalo K, Rafii S: VEGFR-3 and CD133 identify a population of CD34+ lymphatic/vascular endothelial precursor cells.Blood 2003, 101:168-172.
21.
Cho SW, Gwak SJ, Kang SW, Bhang SH, Song KW, Yang YS, Choi CY, Kim BS: Enhancement of Angiogenic Efficacy of Human Cord Blood Cell Transplantation.Tissue Eng 2006.
22.
Botta R, Gao E, Stassi G, Bonci D, Pelosi E, Zwas D, Patti M, Colonna L, Baiocchi M, Coppola S, Ma X, Condorelli G, Peschle C: Heart infarct in NOD-SCID mice: therapeutic vasculogenesis by transplantation of human CD34+ cells and low dose CD34+KDR+ cells.Faseb J 2004, 18:1392-1394.
23.
Le Ricousse-Roussanne S, Barateau V, Contreres JO, Boval B, Kraus-Berthier L, Tobelem G: Ex vivo differentiated endothelial and smooth muscle cells from human cord blood progenitors home to the angiogenic tumor vasculature.Cardiovasc Res 2004, 62:176-184.
24.
Mayer H, Bertram H, Lindenmaier W, Korff T, Weber H, Weich H: Vascular endothelial growth factor (VEGF-A) expression in human mesenchymal stem cells: autocrine and paracrine role on osteoblastic and endothelial differentiation.J Cell Biochem 2005, 95:827-839.
25.
Liu CH, Hwang SM: Cytokine interactions in mesenchymal stem cells from cord blood.Cytokine 2005, 32:270-279.
26.
Gang EJ, Jeong JA, Han S, Yan Q, Jeon CJ, Kim H: In vitro endothelial potential of human UC blood-derived mesenchymal stem cells.Cytotherapy 2006, 8:215-227.
27.
De Ugarte DA, Alfonso Z, Zuk PA, Elbarbary A, Zhu M, Ashjian P, Benhaim P, Hedrick MH, Fraser JK: Differential expression of stem cell mobilization-associated molecules on multi-lineage cells from adipose tissue and bone marrow.Immunol Lett 2003, 89:267-270.
28.
Vaananen HK: Mesenchymal stem cells.Ann Med 2005, 37:469-479.
29.
Knippenberg M, Helder MN, Doulabi BZ, Semeins CM, Wuisman PI, Klein-Nulend J: Adipose tissue-derived mesenchymal stem cells acquire bone cell-like responsiveness to fluid shear stress on osteogenic stimulation.Tissue Eng 2005, 11:1780-1788.
30.
Portmann-Lanz CB, Schoeberlein A, Huber A, Sager R, Malek A, Holzgreve W, Surbek DV: Placental mesenchymal stem cells as potential autologous graft for pre- and perinatal neuroregeneration.Am J Obstet Gynecol 2006, 194:664-673.
31.
Zhang X, Mitsuru A, Igura K, Takahashi K, Ichinose S, Yamaguchi S, Takahashi TA: Mesenchymal progenitor cells derived from chorionic villi of human placenta for cartilage tissue engineering.Biochem Biophys Res Commun 2006, 340:944-952.
32.
Shih DT, Lee DC, Chen SC, Tsai RY, Huang CT, Tsai CC, Shen EY, Chiu WT: Isolation and characterization of neurogenic mesenchymal stem cells in human scalp tissue.Stem Cells 2005, 23:1012-1020.
33.
Kadivar M, Khatami S, Mortazavi Y, Shokrgozar MA, Taghikhani M, Soleimani M: In vitro cardiomyogenic potential of human umbilical vein-derived mesenchymal stem cells.Biochem Biophys Res Commun 2006, 340:639-647.
34.
Fu YS, Cheng YC, Lin MY, Cheng H, Chu PM, Chou SC, Shih YH, Ko MH, Sung MS: Conversion of human umbilical cord mesenchymal stem cells in Wharton's jelly to dopaminergic neurons in vitro: potential therapeutic application for Parkinsonism.Stem Cells 2006, 24:115-124.
35.
Tondreau T, Meuleman N, Delforge A, Dejeneffe M, Leroy R, Massy M, Mortier C, Bron D, Lagneaux L: Mesenchymal stem cells derived from CD133-positive cells in mobilized peripheral blood and cord blood: proliferation, Oct4 expression, and plasticity.Stem Cells 2005, 23:1105-1112.
36.
Jeong JA, Gang EJ, Hong SH, Hwang SH, Kim SW, Yang IH, Ahn C, Han H, Kim H: Rapid neural differentiation of human cord blood-derived mesenchymal stem cells.Neuroreport 2004, 15:1731-1734.
37.
Kang XQ, Zang WJ, Bao LJ, Li DL, Song TS, Xu XL, Yu XJ: Fibroblast growth factor-4 and hepatocyte growth factor induce differentiation of human umbilical cord blood-derived mesenchymal stem cells into hepatocytes.World J Gastroenterol 2005, 11:7461-7465.
38.
Hong SH, Gang EJ, Jeong JA, Ahn C, Hwang SH, Yang IH, Park HK, Han H, Kim H: In vitro differentiation of human umbilical cord blood-derived mesenchymal stem cells into hepatocyte-like cells.Biochem Biophys Res Commun 2005, 330:1153-1161.
39.
Hutson EL, Boyer S, Genever PG: Rapid isolation, expansion, and differentiation of osteoprogenitors from full-term umbilical cord blood.Tissue Eng 2005, 11:1407-1420.
40.
Liu J, Lu XF, Wan L, Li YP, Li SF, Zeng LY, Zeng YZ, Cheng LH, Lu YR, Cheng JQ: Suppression of human peripheral blood lymphocyte proliferation by immortalized mesenchymal stem cells derived from bone marrow of Banna Minipig inbred-line.Transplant Proc 2004, 36:3272-3275.
41.
Togel F, Hu Z, Weiss K, Isaac J, Lange C, Westenfelder C: Administered mesenchymal stem cells protect against ischemic acute renal failure through differentiation-independent mechanisms.Am J Physiol Renal Physiol 2005, 289:F31-42.
42.
Kern S, Eichler H, Stoeve J, Kluter H, Bieback K: Comparative Analysis of Mesenchymal Stem Cells from Bone Marrow, Umbilical Cord Blood or Adipose Tissue.Stem Cells 2006.
43.
Zhao Y, Wang H, Mazzone T: Identification of stem cells from human umbilical cord blood with embryonic and hematopoietic characteristics.Exp Cell Res 2006, 312:2454-2464.
44.
Kogler G, Sensken S, Airey JA, Trapp T, Muschen M, Feldhahn N, Liedtke S, Sorg RV, Fischer J, Rosenbaum C, Greschat S, Knipper A, Bender J, Degistirici O, Gao J, Caplan AI, Colletti EJ, Almeida-Porada G, Muller HW, Zanjani E, Wernet P: A new human somatic stem cell from placental cord blood with intrinsic pluripotent differentiation potential.J Exp Med 2004, 200:123-135.
45.
Zeng F, Chen MJ, Baldwin DA, Gong ZJ, Yan JB, Qian H, Wang J, Jiang X, Ren ZR, Sun D, Huang SZ: Multiorgan engraftment and differentiation of human cord blood CD34+ Lin- cells in goats assessed by gene expression profiling.Proc Natl Acad Sci U S A 2006, 103:7801-7806.
46.
McGuckin CP, Forraz N, Baradez MO, Navran S, Zhao J, Urban R, Tilton R, Denner L: Production of stem cells with embryonic characteristics from human umbilical cord blood.Cell Prolif 2005, 38:245-255.
47.
McGuckin CP, Forraz N, Allouard Q, Pettengell R: Umbilical cord blood stem cells can expand hematopoietic and neuroglial progenitors in vitro.Exp Cell Res 2004, 295:350-359.
48.
McGuckin CP, Forraz N, Pettengell R, Thompson A: Thrombopoietin, flt3-ligand and c-kit-ligand modulate HOX gene expression in expanding cord blood CD133 cells.Cell Prolif 2004, 37:295-306.
49.
Halbrecht J: Fresh and stored placental blood.Lancet 1939, 2:1263.
50.
Hassall O, Bedu-Addo G, Adarkwa M, Danso K, Bates I: Umbilical-cord blood for transfusion in children with severe anaemia in under-resourced countries.Lancet 2003, 361:678-679.
51.
Bhattacharya N: Placental umbilical cord whole blood transfusion: a safe and genuine blood substitute for patients of the under-resourced world at emergency.J Am Coll Surg 2005, 200:557-563.
52.
Bhattacharya N: Placental umbilical cord whole blood transfusion to combat anemia in the background of tuberculosis and emaciation and its potential role as an immuno-adjuvant therapy for the under-resourced people of the world.Clin Exp Obstet Gynecol 2006, 33:99-104.
53.
Bhattacharya N: Placental umbilical cord blood transfusion: A novel method of treatment of patients with malaria in the background of anemia.Clin Exp Obstet Gynecol 2006, 33:39-43.
54.
Bhattacharya N: Placental umbilical cord whole blood transfusion to combat anemia in the background of advanced rheumatoid arthritis and emaciation and its potential role as immunoadjuvant therapy.Clin Exp Obstet Gynecol 2006, 33:28-33.
55.
Bhattacharya N: A preliminary study of placental umbilical cord whole blood transfusion in under resourced patients with malaria in the background of anaemia.Malar J 2006, 5:20.
56.
Bhattacharya N: A preliminary report of 123 units of placental umbilical cord whole blood transfusion in HIV-positive patients with anemia and emaciation.Clin Exp Obstet Gynecol 2006, 33:117-121.
57.
Bhattacharya N: Spontaneous transient rise of CD34 cells in peripheral blood after 72 hours in patients suffering from advanced malignancy with anemia: effect and prognostic implications of treatment with placental umbilical cord whole blood transfusion.Eur J Gynaecol Oncol 2006, 27:286-290.
58.
Ito K, Tanaka T, Tsutsumi N, Obata F, Kashiwagi N: Possible mechanisms of immunotherapy for maintaining pregnancy in recurrent spontaneous aborters: analysis of anti-idiotypic antibodies directed against autologous T-cell receptors.Hum Reprod 1999, 14:650-655.
59.
Smith JB, Cowchock FS, Lata JA, Hankinson BT: The number of cells used for immunotherapy of repeated spontaneous abortion influences pregnancy outcome.J Reprod Immunol 1992, 22:217-224.
60.
Porter D, Levine JE: Graft-versus-host disease and graft-versus-leukemia after donor leukocyte infusion.Semin Hematol 2006, 43:53-61.
61.
Szpakowski A, Malinowski A, Glowacka E, Wilczynski JR, Kolasa D, Dynski M, Tchorzewski H, Zeman K, Szpakowski M: [The influence of paternal lymphocyte immunization on the balance of Th1/Th2 type reactivity in women with unexplained recurrent spontaneous abortion].Ginekol Pol 2000, 71:586-592.
62.
Hayakawa S, Karasaki-Suzuki M, Itoh T, Ishii M, Kanaeda T, Nagai N, Takahashi-Yamamoto N, Tochigi M, Chishima F, Fujii TK, Oyama J, Kitanaka S, Satoh K: Effects of paternal lymphocyte immunization on peripheral Th1/Th2 balance and TCR V beta and V gamma repertoire usage of patients with recurrent spontaneous abortions.Am J Reprod Immunol 2000, 43:107-115.
63.
Marleau AM, Sarvetnick N: T cell homeostasis in tolerance and immunity.J Leukoc Biol 2005, 78:575-584.
64.
Hickman SP, Turka LA: Homeostatic T cell proliferation as a barrier to T cell tolerance.Philos Trans R Soc Lond B Biol Sci 2005, 360:1713-1721.
65.
Rosenberg SA, Dudley ME: Cancer regression in patients with metastatic melanoma after the transfer of autologous antitumor lymphocytes.Proc Natl Acad Sci U S A 2004, 101 Suppl 2:14639-14645.
66.
Hess AD, Bright EC, Thoburn C, Vogelsang GB, Jones RJ, Kennedy MJ: Specificity of effector T lymphocytes in autologous graft-versus-host disease: role of the major histocompatibility complex class II invariant chain peptide.Blood 1997, 89:2203-2209.
67.
Miura Y, Thoburn CJ, Bright EC, Sommer M, Lefell S, Ueda M, Nakao S, Hess AD: Characterization of the T-cell repertoire in autologous graft-versus-host disease (GVHD): evidence for the involvement of antigen-driven T-cell response in the development of autologous GVHD.Blood 2001, 98:868-876.
68.
Maeda A, Schwarz A, Kernebeck K, Gross N, Aragane Y, Peritt D, Schwarz T: Intravenous infusion of syngeneic apoptotic cells by photopheresis induces antigen-specific regulatory T cells.J Immunol 2005, 174:5968-5976.
69.
Vendrame M, Gemma C, de Mesquita D, Collier L, Bickford PC, Sanberg CD, Sanberg PR, Pennypacker KR, Willing AE: Anti-inflammatory effects of human cord blood cells in a rat model of stroke.Stem Cells Dev 2005, 14:595-604
70.
Lo YM, Lo ES, Watson N, Noakes L, Sargent IL, Thilaganathan B, Wainscoat JS: Two-way cell traffic between mother and fetus: biologic and clinical implications.Blood 1996, 88:4390-4395.
71.
Bianchi DW, Zickwolf GK, Weil GJ, Sylvester S, DeMaria MA: Male fetal progenitor cells persist in maternal blood for as long as 27 years postpartum.Proc Natl Acad Sci U S A 1996, 93:705-708.
72.
O'Donoghue K, Chan J, de la Fuente J, Kennea N, Sandison A, Anderson JR, Roberts IA, Fisk NM: Microchimerism in female bone marrow and bone decades after fetal mesenchymal stem-cell trafficking in pregnancy.Lancet 2004, 364:179-182.
73.
Khosrotehrani K, Bianchi DW: Multi-lineage potential of fetal cells in maternal tissue: a legacy in reverse.J Cell Sci 2005, 118:1559-1563.
74.
Johnson KL, Samura O, Nelson JL, McDonnell MWM, Bianchi DW: Significant fetal cell microchimerism in a nontransfused woman with hepatitis C: Evidence of long-term survival and expansion.Hepatology 2002, 36:1295-1297.
75.
Srivatsa B, Srivatsa S, Johnson KL, Samura O, Lee SL, Bianchi DW: Microchimerism of presumed fetal origin in thyroid specimens from women: a case-control study.Lancet 2001, 358:2034-2038.
76.
Khosrotehrani K, Johnson KL, Cha DH, Salomon RN, Bianchi DW: Transfer of fetal cells with multilineage potential to maternal tissue.Jama 2004, 292:75-80.
77.
Khosrotehrani K, Stroh H, Bianchi DW, Johnson KL: Combined FISH and immunolabeling on paraffin-embedded tissue sections for the study of microchimerism.Biotechniques 2003, 34:242-244.
78.
Khosrotehrani K, Bianchi DW: Fetal cell microchimerism: helpful or harmful to the parous woman?Curr Opin Obstet Gynecol 2003, 15:195-199.
79.
Wang Y, Iwatani H, Ito T, Horimoto N, Yamato M, Matsui I, Imai E, Hori M: Fetal cells in mother rats contribute to the remodeling of liver and kidney after injury.Biochem Biophys Res Commun 2004, 325:961-967.
80.
Tan XW, Liao H, Sun L, Okabe M, Xiao ZC, Dawe GS: Fetal microchimerism in the maternal mouse brain: a novel population of fetal progenitor or stem cells able to cross the blood-brain barrier?Stem Cells 2005, 23:1443-1452.
81.
Taupin P: OTI-010 Osiris Therapeutics/JCR Pharmaceuticals.Curr Opin Investig Drugs 2006, 7:473-481.
82.
http://www.clinicaltrials.gov/ct/show/NCT00366145?order=7: .
83.
Kim SW, Han H, Chae GT, Lee SH, Bo S, Yoon JH, Lee YS, Lee KS, Park HK, Kang KS: Successful stem cell therapy using umbilical cord blood-derived multipotent stem cells for Buerger's disease and ischemic limb disease animal model.Stem Cells 2006, 24:1620-1626.
84.
Kang KS, Kim SW, Oh YH, Yu JW, Kim KY, Park HK, Song CH, Han H: A 37-year-old spinal cord-injured female patient, transplanted of multipotent stem cells from human UC blood, with improved sensory perception and mobility, both functionally and morphologically: a case study.Cytotherapy 2005, 7:368-373.
85.
Valbonesi M, Giannini G, Migliori F, Dalla Costa R, Dejana AM: Cord blood (CB) stem cells for wound repair. Preliminary report of 2 cases.Transfus Apher Sci 2004, 30:153-156.
86.
Corso A, Lorenzi A, Zappasodi P, Invernizzi R, Vanelli L, Lazzarino M: Early changes in bone marrow morphology induced by thalidomide in refractory myeloma patients.Haematologica 2003, 88:958-960.
87.
De Felice L, Tatarelli C, Mascolo MG, Gregorj C, Agostini F, Fiorini R, Gelmetti V, Pascale S, Padula F, Petrucci MT, Arcese W, Nervi C: Histone deacetylase inhibitor valproic acid enhances the cytokine-induced expansion of human hematopoietic stem cells.Cancer Res 2005, 65:1505-1513.
88.
Araki H, Mahmud N, Milhem M, Nunez R, Xu M, Beam CA, Hoffman R: Expansion of human umbilical cord blood SCID-repopulating cells using chromatin-modifying agents.Exp Hematol 2006, 34:140-149.
89.
Suzuki M, Harashima A, Okochi A, Yamamoto M, Nakamura S, Motoda R, Yamasaki F, Orita K: 5-Azacytidine supports the long-term repopulating activity of cord blood CD34(+) cells.Am J Hematol 2004, 77:313-315.
90.
Shyu WC, Lee YJ, Liu DD, Lin SZ, Li H: Homing genes, cell therapy and stroke.Front Biosci 2006, 11:899-907.
91.
Fricker SP, Anastassov V, Cox J, Darkes MC, Grujic O, Idzan SR, Labrecque J, Lau G, Mosi RM, Nelson KL, Qin L, Santucci Z, Wong RS: Characterization of the molecular pharmacology of AMD3100: a specific antagonist of the G-protein coupled chemokine receptor, CXCR4.Biochem Pharmacol 2006, 72:588-596.
92.
Son BR, Marquez-Curtis LA, Kucia M, Wysoczynski M, Turner AR, Ratajczak J, Ratajczak MZ, Janowska-Wieczorek A: Migration of bone marrow and cord blood mesenchymal stem cells in vitro is regulated by stromal-derived factor-1-CXCR4 and hepatocyte growth factor-c-met axes and involves matrix metalloproteinases.Stem Cells 2006, 24:1254-1264.
93.
Paczkowska E, Larysz B, Rzeuski R, Karbicka A, Jalowinski R, Kornacewicz-Jach Z, Ratajczak MZ, Machalinski B: Human hematopoietic stem/progenitor-enriched CD34(+) cells are mobilized into peripheral blood during stress related to ischemic stroke or acute myocardial infarction.Eur J Haematol 2005, 75:461-467.
94.
Williams RJ, Clarke E, Blair A, Evely R, Hale G, Waldmann H, Brookes S, Pamphilon DH: Impact on T-cell depletion and CD34+ cell recovery using humanised CD52 monoclonal antibody (CAMPATH-1H) in BM and PSBC collections; comparison with CAMPATH-1M and CAMPATH-1G.Cytotherapy 2000, 2:5-14.
95.
Gennery AR, Dickinson AM, Brigham K, Barge D, Spickett GP, Curtis A, Spencer V, Jackson A, Cavanagh G, Carter V, Palmer P, Flood TJ, Cant AJ, Abinun M: CAMPATH-1M T-cell depleted BMT for SCID: long-term follow-up of 19 children treated 1987-98 in a single center.Cytotherapy 2001, 3:221-232.
96.
Klangsinsirikul P, Carter GI, Byrne JL, Hale G, Russell NH: Campath-1G causes rapid depletion of circulating host dendritic cells (DCs) before allogeneic transplantation but does not delay donor DC reconstitution.Blood 2002, 99:2586-2591.
97.
Ratzinger G, Reagan JL, Heller G, Busam KJ, Young JW: Differential CD52 expression by distinct myeloid dendritic cell subsets: implications for alemtuzumab activity at the level of antigen presentation in allogeneic graft-host interactions in transplantation.Blood 2003, 101:1422-1429.
98.
Staba SL, Escolar ML, Poe M, Kim Y, Martin PL, Szabolcs P, Allison-Thacker J, Wood S, Wenger DA, Rubinstein P, Hopwood JJ, Krivit W, Kurtzberg J: Cord-blood transplants from unrelated donors in patients with Hurler's syndrome.N Engl J Med 2004, 350:1960-1969.
99.
Zhang C, Chen W, Xiao LL, Tan EX, Luo SK, Zheng D, Ye X, Li Z, Lu XL, Liu Y: [Allogeneic umbilical cord blood stem cell transplantation in Duchenne muscular dystrophy].Zhonghua Yi Xue Za Zhi 2005, 85:522-525.
100.
Jaing TH, Hou JW, Chen SH, Huang IA, Wang CJ, Lee WI: Successful unrelated mismatched cord blood transplantation in a child with malignant infantile osteopetrosis.Pediatr Transplant 2006, 10:629-631.
101.
Tomizawa D, Aoki Y, Nagasawa M, Morio T, Kajiwara M, Sekine T, Shimizu N, Kato M, Yachie A, Mizutani S: Novel adopted immunotherapy for mixed chimerism after unrelated cord blood transplantation in Omenn syndrome.Eur J Haematol 2005, 75:441-444.
102.
Ooi J, Iseki T, Takahashi S, Tomonari A, Takasugi K, Uchiyama M, Konuma T, Fukuno K, Soda Y, Ohno N, Nagamura F, Uchimaru K, Tojo A, Asano S: Unrelated cord blood transplantation after myeloablative conditioning for adult patients with refractory anemia.Int J Hematol 2005, 81:424-427.
103.
Azuma E, Hirayama M, Bonno M, Iwamoto S, Kumamoto T, Kobayashi M, Komada Y, Taniguchi K, Nakano T, Kamiya H: Successful immunization following cord blood transplantation in a child with Diamond-Blackfan anemia.Pediatr Hematol Oncol 2001, 18:193-197.
104.
Ishimura M, Ohga S, Nomura A, Toubo T, Morihana E, Saito Y, Nishio H, Ide M, Takada H, Hara T: Successful umbilical cord blood transplantation for severe chronic active Epstein-Barr virus infection after the double failure of hematopoietic stem cell transplantation.Am J Hematol 2005, 80:207-212.
105.
Mullen CA, Thompson JN, Richard LA, Chan KW: Unrelated umbilical cord blood transplantation in infancy for mucopolysaccharidosis type IIB (Hunter syndrome) complicated by autoimmune hemolytic anemia.Bone Marrow Transplant 2000, 25:1093-1097.
Answers to all your Biology Questions
